Does Ashwagandha Interact With Lexapro?

There is credible evidence that ashwagandha can interact with Lexapro (escitalopram), and the combination has been linked to at least one documented case of serotonin syndrome, a potentially dangerous condition caused by excessive serotonergic activity in the brain. The interaction is not yet well-characterized by large clinical trials, but the case report, combined with what researchers know about how both substances affect the nervous system, gives real reason for caution. The picture is more complicated than a simple yes-or-no drug interaction, because ashwagandha influences multiple biological systems that overlap with what Lexapro does.

A Documented Case of Serotonin Syndrome

The most direct piece of evidence comes from a case report presented in Neurology, documenting serotonin syndrome in a patient who was taking both ashwagandha (Withania somnifera) and escitalopram.¹ Serotonin syndrome occurs when the brain accumulates too much serotonin, and it can range from mild symptoms like agitation, rapid heartbeat, and diarrhea to severe, life-threatening complications including high fever, seizures, and muscle rigidity. It most often happens when two or more substances that boost serotonin levels are used together.

Lexapro is a selective serotonin reuptake inhibitor, so its entire mechanism revolves around increasing serotonin availability in the brain. The fact that adding ashwagandha pushed a patient into serotonin syndrome strongly suggests ashwagandha was contributing its own serotonergic activity on top of what Lexapro was already doing. A single case report does not prove that the combination is dangerous for everyone, but it does establish that the interaction is pharmacologically plausible and has produced real harm in at least one person.

Why Ashwagandha Might Amplify Serotonin Effects

Ashwagandha is not typically thought of as a serotonergic substance in the way that St. John’s Wort is, which is part of why many people assume it is safe to combine with SSRIs. But the herb has broad neuroactive properties. Animal and cell studies show that ashwagandha root extracts increase the expression of GABA receptors and influence histamine pathways involved in sleep and arousal.² Other research has confirmed that ashwagandha root extract promotes deep sleep by acting through GABA receptors, increasing both the duration and quality of non-rapid eye movement sleep.³

GABA and serotonin systems are not the same thing, but they interact extensively within the brain. Enhancing GABA activity can change how the brain responds to serotonin, and substances that affect both systems simultaneously create a more complex pharmacological picture than either one alone. The withanolides in ashwagandha, the plant’s primary active compounds, appear to have effects across multiple neurotransmitter systems. This broad activity profile is part of what makes ashwagandha useful for stress and sleep, but it is also what creates the potential for unpredictable interactions with a drug that already alters brain chemistry.

What Enzyme Research Shows About Drug Metabolism

When pharmacologists evaluate drug interactions, they look at two main angles. One is pharmacodynamic: do the two substances affect the same biological targets, potentially amplifying or canceling each other’s effects? The other is pharmacokinetic: does one substance change how quickly the body processes the other, raising or lowering blood levels of the drug?

On the pharmacokinetic side, the news is somewhat reassuring but incomplete. Escitalopram is broken down primarily by the CYP2C19 enzyme in the liver.⁴ Variations in how actively that enzyme works can have dramatic effects on drug levels: people with certain genetic profiles can end up with escitalopram concentrations more than three times higher than normal, while others clear the drug faster than average. This matters because anything that inhibits CYP2C19 could effectively raise Lexapro levels and intensify both its therapeutic effects and side effects.

Laboratory studies on ashwagandha extracts have looked at several liver enzymes. One study testing four different ashwagandha extracts (from both root and leaf) found no meaningful reversible inhibition of cytochrome P450 enzymes at concentrations likely to be encountered in real-world supplement use.⁵ A separate study using human liver cells found that a particular ethanol-based root extract did modulate CYP3A4, a different enzyme involved in drug metabolism, though CYP3A4 plays a secondary role in escitalopram clearance compared to CYP2C19.⁶

So the laboratory evidence so far does not point to a dramatic pharmacokinetic interaction between ashwagandha and Lexapro through the main metabolic pathway. But these are cell-culture studies, not studies in living humans taking both substances. And the fact that ashwagandha can influence at least some liver enzymes means the door is not fully closed. The more concerning interaction pathway remains pharmacodynamic: ashwagandha’s direct effects on the brain, layered on top of what Lexapro is already doing.

The Cortisol Question

One of the most popular reasons people take ashwagandha alongside an antidepressant is to address stress and anxiety more aggressively. Ashwagandha has a solid track record for lowering cortisol, the body’s primary stress hormone. A placebo-controlled trial found that ashwagandha supplementation led to a roughly 23% reduction in cortisol levels over the study period, while the placebo group showed essentially no change.⁷ Meta-analyses pooling data from multiple trials have confirmed that ashwagandha consistently lowers cortisol and reduces scores on standard stress and anxiety questionnaires compared to placebo.⁸⁹

This cortisol-lowering effect is not inherently problematic when combined with Lexapro, but it adds a layer of complexity. Cortisol interacts with serotonin signaling, and chronically elevated cortisol can dampen serotonin receptor sensitivity. Lowering cortisol could, in theory, make serotonin receptors more responsive, which might subtly amplify the effect of an SSRI. Whether this theoretical pathway plays out meaningfully in real patients is unknown, but it is one more mechanism through which the two substances could interact in ways that are hard to predict from studying either one alone.

One trial compared a standardized ashwagandha extract directly against sertraline (a different SSRI) for generalized anxiety and found comparable reductions in anxiety scores, with ashwagandha producing about a 24% drop in cortisol.¹⁰ The fact that ashwagandha can produce anti-anxiety effects in a similar range to an SSRI reinforces the point that it is a pharmacologically active substance, not a neutral supplement. Stacking two pharmacologically active anti-anxiety agents is not automatically dangerous, but it is also not the same as taking a multivitamin with your medication.

Ashwagandha’s Effects on the Liver

Beyond the brain-chemistry concerns, there is a separate safety issue worth knowing about: ashwagandha has been linked to liver injury in a growing number of case reports from multiple countries. One well-documented case involved a patient who developed acute hepatitis after taking ashwagandha for a year, with lab work showing elevated bilirubin, liver enzymes, and other markers of liver damage.¹¹ Similar cases have been reported in Japan, Iceland, India, and the United States.

This matters in the Lexapro context because escitalopram is also metabolized by the liver. If ashwagandha is stressing liver function, even subclinically, it could change how efficiently the liver clears Lexapro. Liver injury from ashwagandha appears to be rare, and many people take the supplement without obvious liver problems, but you would not necessarily know you were developing mild liver stress until it showed up on blood work. For someone already taking a liver-metabolized medication daily, adding another substance with documented hepatotoxicity potential is worth discussing with a doctor, particularly if you plan to use ashwagandha long-term.

The Supplement Quality Problem

Even setting aside the pharmacological interaction question, there is a practical issue that makes predicting any supplement-drug interaction harder: ashwagandha supplements vary wildly in what they actually contain. A recent comparison of 25 ashwagandha products on the market found that over 44% failed to meet British Pharmacopoeia standards, and 60% failed to meet US Pharmacopoeia standards for withanolide content.¹² Only 10 of the 25 products met both standards. Part of the problem was that many products contained leaf material rather than pure root, despite labeling claims. This matters because the chemical profile of ashwagandha leaves differs from the root, with different concentrations of active compounds.

For someone taking Lexapro, this inconsistency makes the risk calculus even murkier. The interaction profile of a high-quality, root-only, standardized extract might be different from that of a cheap product containing an unknown mix of plant parts. You cannot reliably dose-adjust or predict interactions when the active ingredient content varies by a factor of two or more between brands, or even between batches of the same brand. If you are considering combining ashwagandha with any prescription medication, choosing a product that has been independently tested and verified to contain what it claims is not just good practice; it is a basic safety measure.

Who Should Be Most Cautious

Certain people face higher risk from this combination than others. If you are a CYP2C19 poor metabolizer, meaning your body clears escitalopram slowly and your blood levels of the drug run high, anything that further increases serotonergic tone or even modestly affects drug clearance is more likely to tip you into adverse territory. Roughly 2-3% of people of European descent and a larger share of people of East Asian descent carry genetic variants that substantially reduce CYP2C19 activity. If you have ever been told you are a slow metabolizer, or if you have experienced unusual sensitivity to Lexapro at low doses, the risk of adding ashwagandha is higher for you than for the average person.

People taking higher doses of Lexapro (the maximum recommended dose is 20 mg per day) have less room for error, because their serotonin levels are already being pushed harder. Similarly, anyone taking other serotonergic substances, whether prescription (triptans, tramadol, lithium) or over-the-counter (certain cough medications containing dextromethorphan), is stacking yet another variable on top of what is already a complex situation.

Older adults and people with pre-existing liver conditions should also exercise extra caution, given ashwagandha’s documented liver toxicity potential and the fact that liver function tends to decline with age, slowing drug metabolism across the board.

What Ashwagandha and Lexapro Share as Targets

Part of the appeal of combining these two substances is that they seem to address overlapping problems from different angles. Lexapro targets anxiety and depression through serotonin. Ashwagandha targets stress through cortisol modulation, sleep through GABA enhancement, and anxiety through mechanisms that may partly overlap with SSRIs. The idea of attacking a mental health problem from multiple biological pathways simultaneously is not inherently wrong, and some psychiatrists do use combination strategies. But the key difference is that when a psychiatrist adds a second medication, both drugs have known pharmacokinetics, standardized dosing, and well-characterized interaction profiles.

With ashwagandha, you are adding a multi-target botanical whose interaction profile with SSRIs has not been studied in controlled human trials. The serotonin syndrome case report exists, the enzyme data is mixed, the cortisol effects are real, and the GABA activity is documented, but nobody has run a proper trial giving both substances to a group of patients and monitoring what happens. That is the fundamental gap in the evidence. The individual pieces of data suggest that the interaction is pharmacologically plausible and has caused harm at least once. What they cannot tell you is how common or how dose-dependent that risk is.

How Ashwagandha Products Are Typically Used

Most ashwagandha supplements on the market are sold as root extracts, often standardized to a certain percentage of withanolides. Common daily doses in clinical trials have ranged from about 300 mg to 600 mg of root extract, with some studies using higher amounts. The anxiolytic trial that compared ashwagandha head-to-head with sertraline used 600 mg per day of a standardized root extract.¹⁰ Many consumer products recommend doses in that range or higher, and some formulations combine ashwagandha with other herbs or adaptogens that have their own pharmacological activity.

People often start taking ashwagandha without mentioning it to their prescribing doctor, partly because supplements are seen as “natural” and therefore low-risk, and partly because the conversation can feel awkward. But your prescriber needs to know about anything pharmacologically active you are taking, especially something that affects neurotransmitter systems and liver enzymes. The case report of serotonin syndrome from the ashwagandha-escitalopram combination was only identified because clinicians recognized the symptoms and asked about supplement use. If you are already taking both and feel fine, that does not mean the interaction is absent; it means it has not manifested in a way you have noticed. Subclinical effects on serotonin signaling or liver function would not necessarily produce obvious symptoms until they crossed a threshold.

When the Combination Might Make Sense Under Supervision

None of this means that ashwagandha is categorically forbidden for anyone taking Lexapro. The serotonin syndrome case report is a single documented instance, and millions of people take ashwagandha worldwide. The probability of a severe interaction for any individual person may be low. But “probably fine” and “proven safe” are different things, and the distinction matters when one of the substances is a prescription medication managing a serious condition.

If you want to try ashwagandha for stress, sleep, or residual anxiety while on Lexapro, the safest approach involves your prescriber. They can consider your specific dose of escitalopram, your metabolizer status if known, your other medications, and your liver function. Starting ashwagandha at a low dose and increasing gradually, while monitoring for early signs of serotonergic excess (restlessness, muscle twitching, rapid pulse, sweating, confusion), gives you the best chance of catching a problem before it becomes serious. Keeping your doctor informed also means that if something does go wrong, the cause can be identified quickly rather than missed because nobody knew you were taking a supplement.